The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Theuer Charles since 2015.
This trader's CIK number is 1631338.
At the time of last reporting, Theuer Charles was the President and CEO of Tracon Pharmaceuticals, Inc.. (stock ticker symbol TCON).
Also see all insider trading activities at Tracon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | TCON | 62,799 | $56,505 | 0 | $0 | 0 | $0 |
| 2022 | TCON | 106,800 | $180,710 | 0 | $0 | 0 | $0 |
| 2021 | TCON | 22,181 | $134,931 | 0 | $0 | 0 | $0 |
| 2020 | TCON | 172,755 | $321,843 | 0 | $0 | 0 | $0 |
| 2019 | TCON | 50,000 | $22,500 | 0 | $0 | 0 | $0 |
| 2018 | TCON | 49,000 | $32,242 | 0 | $0 | 0 | $0 |
| 2015 | TCON | 0 | $0 | 13,616 | $216,792 | 10,000 | $7,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-27 | TCON | Buy | 47,000 | .75 | 35,250 |
| 2023-04-26 | TCON | Buy | 3,999 | .66 | 2,639 |
| 2023-02-28 | TCON | Buy | 200 | 1.52 | 304 |
| 2023-03-01 | TCON | Buy | 4,800 | 1.52 | 7,296 |
| 2023-01-18 | TCON | Buy | 6,800 | 1.62 | 11,016 |
| 2022-12-14 | TCON | Buy | 23,000 | 1.29 | 29,762 |
| 2022-11-18 | TCON | Buy | 13,900 | 1.41 | 19,599 |
| 2022-11-03 | TCON | Buy | 9,200 | 1.52 | 13,984 |
| 2022-11-02 | TCON | Buy | 6,000 | 1.59 | 9,540 |
| 2022-10-07 | TCON | Buy | 5,000 | 1.77 | 8,850 |
| 2022-10-03 | TCON | Buy | 5,000 | 1.67 | 8,350 |
| 2022-09-22 | TCON | Buy | 5,000 | 1.76 | 8,800 |
| 2022-07-22 | TCON | Buy | 4,500 | 1.85 | 8,325 |
| 2022-07-13 | TCON | Buy | 3,000 | 1.84 | 5,520 |
| 2022-07-12 | TCON | Buy | 3,000 | 1.87 | 5,610 |
| 2022-05-09 | TCON | Buy | 10,000 | 1.85 | 18,500 |
| 2022-05-06 | TCON | Buy | 2,500 | 1.97 | 4,925 |
| 2022-04-29 | TCON | Buy | 5,000 | 1.97 | 9,855 |
| 2022-04-21 | TCON | Buy | 4,500 | 2.30 | 10,350 |
| 2022-04-08 | TCON | Buy | 2,000 | 2.50 | 5,000 |
| 2022-03-30 | TCON | Buy | 4,000 | 2.70 | 10,800 |
| 2022-03-21 | TCON | Buy | 1,200 | 2.45 | 2,940 |
| 2021-11-18 | TCON | Buy | 681 | 2.88 | 1,961 |
| 2021-11-19 | TCON | Buy | 3,500 | 2.82 | 9,870 |
| 2021-11-05 | TCON | Buy | 4,000 | 3.41 | 13,652 |
| 2021-08-16 | TCON | Buy | 3,000 | 3.56 | 10,680 |
| 2021-01-27 | TCON | Buy | 11,000 | 8.98 | 98,768 |
| 2020-12-29 | TCON | Buy | 1,000 | 9.98 | 9,980 |
| 2020-10-21 | TCON | Buy | 2,000 | 4.38 | 8,770 |
| 2020-09-23 | TCON | Buy | 5,000 | 4.72 | 23,600 |
| 2020-09-04 | TCON | Buy | 10,000 | 2.58 | 25,750 |
| 2020-08-21 | TCON | Buy | 5,325 | 1.56 | 8,307 |
| 2020-08-20 | TCON | Buy | 30,000 | 1.58 | 47,400 |
| 2020-08-18 | TCON | Buy | 44,743 | 1.63 | 72,841 |
| 2020-08-14 | TCON | Buy | 100 | 1.70 | 170 |
| 2020-08-13 | TCON | Buy | 5,000 | 1.65 | 8,250 |
| 2020-08-12 | TCON | Buy | 15,000 | 1.73 | 25,950 |
| 2020-06-24 | TCON | Buy | 9,895 | 1.90 | 18,800 |
| 2020-05-22 | TCON | Buy | 10,592 | 1.90 | 20,071 |
| 2020-03-13 | TCON | Buy | 4,100 | 1.13 | 4,624 |
| 2020-03-11 | TCON | Buy | 10,000 | 1.68 | 16,840 |
| 2020-03-12 | TCON | Buy | 10,000 | 1.18 | 11,800 |
| 2020-03-10 | TCON | Buy | 10,000 | 1.87 | 18,690 |
| 2019-08-09 | TCON | Buy | 50,000 | .45 | 22,500 |
| 2018-12-21 | TCON | Buy | 49,000 | .66 | 32,242 |
| 2015-09-18 | TCON | Option Ex | 10,000 | .70 | 7,000 |
| 2015-09-18 | TCON | Sale | 10,000 | 17.34 | 173,400 |
| 2015-09-10 | TCON | Sale | 3,516 | 12.00 | 42,192 |
| 2015-08-14 | TCON | Sale | 100 | 12.00 | 1,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Theuer Charles (President and CEO of Tracon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.